0000899243-18-017609.txt : 20180621
0000899243-18-017609.hdr.sgml : 20180621
20180621164624
ACCESSION NUMBER: 0000899243-18-017609
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180619
FILED AS OF DATE: 20180621
DATE AS OF CHANGE: 20180621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Todd C
CENTRAL INDEX KEY: 0001392029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 18912246
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-19
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001392029
Davis Todd C
3911 SORRENTO VALLEY BOULEVARD,
SUITE 110
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2018-06-19
4
A
0
493
0.00
A
54056
D
Non-Qualified Stock Option (right to buy)
76.77
2018-06-19
4
A
0
2474
0.00
A
2028-06-18
Common Stock
2474
2474
D
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
/s/ Charles S. Berkman, Attorney-in-Fact
2018-06-21